Descrizione

Subgroup analysis of probiotic efficacy by IBS subtype from the systematic review, comparing outcomes in diarrhea-predominant, constipation-predominant, and mixed-type IBS. Certain probiotic strains appear more effective for specific subtypes.

Figure 4

Chart

Source Paper

Evaluating the Efficacy of Probiotics in IBS Treatment Using a Systematic Review of Clinical Trials and Multi-Criteria Decision Analysis.

Nutrients (2022)

PMID: 35807868

DOI: 10.3390/nu14132689

Cite This Figure

![Figure 4: Subgroup analysis of probiotic efficacy by IBS subtype from the systematic review, comparing outcomes in diarrhea-predominant, constipation-predominant, and mixed-type IBS. Certain probiotic strains appear more effective for specific subtypes.]()

> Source: Cecilia Ceccherini et al. "Evaluating the Efficacy of Probiotics in IBS Treatment Using a Systematic Review." *Nutrients*, 2022. PMID: [35807868](https://pubmed.ncbi.nlm.nih.gov/35807868/)

<figure>
  <img src="" alt="Subgroup analysis of probiotic efficacy by IBS subtype from the systematic review, comparing outcomes in diarrhea-predominant, constipation-predominant, and mixed-type IBS. Certain probiotic strains appear more effective for specific subtypes." />
  <figcaption>Figure 4. Subgroup analysis of probiotic efficacy by IBS subtype from the systematic review, comparing outcomes in diarrhea-predominant, constipation-predominant, and mixed-type IBS. Certain probiotic strains appear more effective for specific subtypes.<br>  Source: Cecilia Ceccherini et al. "Evaluating the Efficacy of Probiotics in IBS Treatment Using a Systematic Review." <em>Nutrients</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35807868/">35807868</a></figcaption>
</figure>

Evidenze correlate

Lactobacillus acidophilus per Irritable Bowel Syndrome (IBS)

Grado B · 3 studi